Nicotinic Receptors and Calcium Channels in Small Cell Lung Carcinoma: Functional Role, Modulation, and Autoimmunity a

[1]  B. Dargent,et al.  Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum , 1996, Annals of neurology.

[2]  A. Grinnell,et al.  Lambert‐eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small‐cell lung carcinoma , 1996, Annals of neurology.

[3]  R. Gray,et al.  Hippocampal synaptic transmission enhanced by low concentrations of nicotine , 1996, Nature.

[4]  S. Nagataki,et al.  Specificity of autoantibodies react with ω‐conotoxin MVIIC‐sensitive calcium channel in Lambert‐Eaton myasthenic syndrome , 1996, Muscle and Nerve.

[5]  K. Beam,et al.  Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Beam,et al.  Reduction of Calcium Currents by Lambert–Eaton Syndrome Sera: Motoneurons Are Preferentially Affected, and L-Type Currents Are Spared , 1996, The Journal of Neuroscience.

[7]  P. Cesare,et al.  Activation of δ-Opioid Receptors Inhibits Neuronal-Like Calcium Channels and Distal Steps of Ca2+-Dependent Secretion in Human Small-Cell Lung Carcinoma Cells , 1996, The Journal of Neuroscience.

[8]  E. Sher,et al.  Down‐regulation of non‐L‐, non‐N‐type (Q‐like) Ca2+ channels by Lambert‐Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells , 1996, FEBS letters.

[9]  D. Protti,et al.  Calcium channel blockers and transmitter release at the normal human neurornuscular junction , 1996, Neurology.

[10]  E. Sher,et al.  α-Conotoxin imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuroendocrine carcinoma cells , 1996, Neuroscience Letters.

[11]  T. O'shaughnessy,et al.  Inhibition of calcium currents and exocytosis by Lambert‐Eaton syndrome antibodies in human lung cancer cells. , 1995, The Journal of physiology.

[12]  M. Conklin,et al.  Decreased calcium currents in motor nerve terminals of mice with Lambert‐Eaton myasthenic syndrome. , 1995, The Journal of physiology.

[13]  S. Heinemann,et al.  alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors. , 1995, Molecular pharmacology.

[14]  P. O'Suilleabhain,et al.  Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. , 1995, The New England journal of medicine.

[15]  I. Cooke,et al.  Characterization of the Ca2+ current in freshly dissociated crustacean peptidergic neuronal somata. , 1995, Journal of neurophysiology.

[16]  E. Barry,et al.  Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  A. Vincent,et al.  An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[18]  E. Sher,et al.  Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs , 1994, Neuroscience Letters.

[19]  J. Minna,et al.  Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  J. Patrick,et al.  α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line , 1994, Brain Research.

[21]  S. Froehner,et al.  α1 and α2 Ca2+ channel subunit expression in human neuronal and small cell carcinoma cells , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  F. Clementi,et al.  ω-Conotoxin GVIA binds to and blocks rat neuromuscular junction , 1994, Neuroscience Letters.

[23]  D. Yoshikami,et al.  A nicotinic acetylcholine receptor ligand of unique specificity, alpha-conotoxin ImI. , 1994, The Journal of biological chemistry.

[24]  E. Sher,et al.  Serotonin release and cell proliferation are under the control of α‐bungarotoxin‐sensitive nicotinic receptors in small‐cell lung carcinoma cell lines , 1994, FEBS letters.

[25]  J. Newsom-Davis,et al.  Heterogeneity of calcium channel autoantibodies detected using a small‐cell lung cancer line derived from a Lambert‐Eaton myasthenic syndrome patient , 1994, Neurology.

[26]  E. Sher,et al.  Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. , 1993, The Journal of biological chemistry.

[27]  D. Protti,et al.  Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin ω-Aga-IVA , 1993 .

[28]  E. Sher,et al.  Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. , 1993, Cancer research.

[29]  T. O'shaughnessy,et al.  Inhibitory Action of Lambert‐Eaton Syndrome IgG on Calcium Currents in a Thyroid C‐Cell Line a , 1993, Annals of the New York Academy of Sciences.

[30]  E. Sher,et al.  Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. , 1993, The American review of respiratory disease.

[31]  E. Sher,et al.  Cloning and characterization of a lambert‐eaton myasthenic syndrome antigen , 1993, Annals of neurology.

[32]  E. Sher,et al.  Neuronal‐type nicotinic receptors in human neuroblastoma and small‐cell lung carcinoma cell lines , 1992, FEBS letters.

[33]  E. Biancardi,et al.  ω-Conotoxin-sensitive, voltage-operated Ca2+ channels in insulin-secreting cells , 1992 .

[34]  E. Sher,et al.  Neuronal-type alpha-bungarotoxin receptors and the alpha 5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  F. Clementi,et al.  ω-Conotoxin-sensitive voltage-operated calcium channels in vertebrate cells , 1991, Neuroscience.

[36]  M. Passafaro,et al.  Physiopathology of neuronal voltage‐operated calcium channels , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  M. Passafaro,et al.  Presynaptic localization of ω-conotoxin-sensitive calcium channels at the frog neuromuscular junction , 1991, Brain Research.

[38]  J. Newsom-Davis,et al.  Calcium channel autoantibodies in the lambert‐eaton myasthenic syndrome , 1991, Lancet.

[39]  A. Luca,et al.  Effects of ω‐conotoxin GVIA on autonomic neuroeffector transmission in various tissues , 1990 .

[40]  E. Sher,et al.  Voltage-operated calcium channels in small cell lung carcinoma cell lines: pharmacological, functional, and immunological properties. , 1990, Cancer research.

[41]  J. Minna,et al.  Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Peers,et al.  Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line. , 1990, The Journal of physiology.

[43]  V. Lennon,et al.  Activation of M3 muscarinic acetylcholine receptors inhibits voltage-dependent calcium influx in small cell lung carcinoma. , 1990, The Journal of biological chemistry.

[44]  A. Vincent,et al.  Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder , 1989, Trends in Neurosciences.

[45]  V. Lennon,et al.  Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. , 1989, Mayo Clinic proceedings.

[46]  J. Pancrazio,et al.  Voltage-dependent ion channels in small-cell lung cancer cells. , 1989, Cancer research.

[47]  E. Sher,et al.  SPECIFICITY OF CALCIUM CHANNEL AUTOANTIBODIES IN LAMBERT-EATON MYASTHENIC SYNDROME , 1989, The Lancet.

[48]  V. Lennon,et al.  Selected IgG rapidly induces Lambert–Eaton myasthenic syndrome in mice: Complement independence and EMG abnormalities , 1988, Muscle & nerve.

[49]  V. Lennon,et al.  Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine. , 1988, Cancer research.

[50]  E. Neher,et al.  IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. , 1988, Science.

[51]  R. Macleod,et al.  Immunoglobulins of Lambert‐Eaton myasthenic syndrome inhibit rat pituitary hormone release , 1987, Annals of neurology.

[52]  W. Ross,et al.  Effects of serum-fractions from patients with Eaton-Lambert syndrome on rat cortical synaptosomal [3H]acetylcholine release. , 1986, Biochemical pharmacology.

[53]  Yong I. Kim.  Passively transferred lambert‐eaton syndrome in mice receiving purified IgG , 1986, Muscle & nerve.

[54]  A. Vincent,et al.  Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line , 1985, Nature.

[55]  J. Cunningham,et al.  Acetylcholine Receptors in Small Cell Carcinomas , 1985, Journal of neurochemistry.

[56]  G. Sorenson,et al.  Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung. , 1981, Science.